Assessing the effectiveness of Xeomin injections for Tinnitus
Completed Phase 2 NCT05650645
Study Description
Tinnitus is a common condition that is characterized by nonstop ringing in the ears. Xeomin (incobotulinumtoxinA) injections into the auricular muscles has been studied to assess its effectiveness in relieving tinnitus. The study utilized the Tinnitus Handicap Inventory questionnaire to gauge the patient-reported effectiveness of the treatment. The results of the study can provide valuable insight into the use of Xeomin injections as a possible tinnitus treatment option.
Study Details
- Registry ID:
- NCT05650645
- Conditions:
- Tinnitus
- Phase:
- Phase 2
- Target Enrollment:
- 41 participants
- Start Date:
- Age Range:
- 18–999 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
University of Minnesota
Minneapolis, Minnesota, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.